{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:55Z","timestamp":1792291015126,"version":"4.4.0"},"reference-count":56,"publisher":"Keio Journal of Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2302\/kjm.61.47","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T18:06:04Z","timestamp":1340733964000},"page":"47-56","source":"Crossref","is-referenced-by-count":114,"title":["Tumor Angiogenesis and Anti-angiogenic Therapy"],"prefix":"10.2302","volume":"61","author":[{"given":"Yoshiaki","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.\u7ab6\u30fbarmelietP:Angiogenesis in life, disease and medicine.Nature2005;438:932\u7ab6\u9aad\u0080936.","DOI":"10.1038\/nature04478"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.\u7ab6\uff13isauW:Mechanisms of angiogenesis.Nature1997;386:671\u7ab6\u9aad\u0080674.","DOI":"10.1038\/386671a0"},{"key":"3","unstructured":"4.\u7ab6\u30fbdeAG,BakerNH,WarrenSL:Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber.AJR Am J Roentgenol1939;42:891\u7ab6\u9aad\u0080899."},{"key":"4","doi-asserted-by":"crossref","unstructured":"5.\u7ab6\u30fblgireGH,ChalkleyHW,LegallaisFY,ParkHD:Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants.J Natl Cancer Inst1945;6:73\u7ab6\u9aad\u008085.","DOI":"10.1093\/jnci\/6.1.73"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6.\u7ab6\u30fbolkmanJ:Tumor angiogenesis: therapeutic implications.N Engl J Med1971;285:1182\u7ab6\u9aad\u00801186.","DOI":"10.1056\/NEJM197111182852108"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7.\u7ab6\uff14engerDR,GalliSJ,DvorakAM,PerruzziCA,HarveyVS,DvorakHF:Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.Science1983;219:983\u7ab6\u9aad\u0080985.","DOI":"10.1126\/science.6823562"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8.\u7ab6\u30fberraraN:VEGF-A: a critical regulator of blood vessel growth.Eur Cytokine Netw2009;20:158\u7ab6\u9aad\u0080163.","DOI":"10.1684\/ecn.2009.0170"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9.\u7ab6\u30fbarmelietP,DorY,HerbertJM,FukumuraD,BrusselmansK,DewerchinM,NeemanM,BonoF,AbramovitchR,MaxwellP,KochCJ,RatcliffeP,MoonsL,JainRK,CollenD,KeshertE:Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.Nature1998;394:485\u7ab6\u9aad\u0080490.","DOI":"10.1038\/28867"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10.\u7ab6\uff14emenzaGL,AganiF,IyerN,KotchL,LaughnerE,LeungS,YuA:Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1.Ann N Y Acad Sci1999;874:262\u7ab6\u9aad\u0080268.","DOI":"10.1111\/j.1749-6632.1999.tb09241.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11.\u7ab6\u30fbukumuraD,XavierR,SugiuraT,ChenY,ParkEC,LuN,SeligM,NielsenG,TaksirT,JainRK,SeedB:Tumor induction of VEGF promoter activity in stromal cells.Cell1998;94:715\u7ab6\u9aad\u0080725.","DOI":"10.1016\/S0092-8674(00)81731-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12.\u7ab6\u30fbimKJ,LiB,WinerJ,ArmaniniM,GillettN,PhillipsHS,FerraraN:Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.Nature1993;362:841\u7ab6\u9aad\u0080844.","DOI":"10.1038\/362841a0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13.\u7ab6\u30fberraraN,KerbelRS:Angiogenesis as a therapeutic target.Nature2005;438:967\u7ab6\u9aad\u0080974.","DOI":"10.1038\/nature04483"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14.\u7ab6\u30fbragoudasES,AdamisAP,CunninghamETJr,FeinsodM,GuyerDR:Pegaptanib for neovascular age-related macular degeneration.N Engl J Med2004;351:2805\u7ab6\u9aad\u00802816.","DOI":"10.1056\/NEJMoa042760"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15.\u7ab6\u30fbarmelietP,JainRK:Molecular mechanisms and clinical applications of angiogenesis.Nature2011;473:298\u7ab6\u9aad\u0080307.","DOI":"10.1038\/nature10144"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17.\u7ab6\u30fbancusoMR,DavisR,NorbergSM,O\u2019BrienS,SenninoB,NakaharaT,YaoVJ,InaiT,BrooksP,FreimarkB,ShalinskyDR,Hu-LoweDD,McDonaldDM:Rapid vascular regrowth in tumors after reversal of VEGF inhibition.J Clin Invest2006;116:2610\u7ab6\u9aad\u00802621.","DOI":"10.1172\/JCI24612"},{"key":"16","doi-asserted-by":"crossref","unstructured":"19.\u7ab6\uff13atnerM:Genentech discloses safety concerns over Avastin.Nat Biotechnol2004;22:1004\u7ab6\u9aad\u00801198.","DOI":"10.1038\/nbt1004-1198"},{"key":"17","doi-asserted-by":"crossref","unstructured":"20.\u7ab6\u30fbaharajAS,WalsheTE,Saint-GeniezM,VenkateshaS,MaldonadoAE,HimesNC,MatharuKS,KarumanchiSA,D\u2019AmorePA:VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.J Exp Med2008;205:491\u7ab6\u9aad\u0080501.","DOI":"10.1084\/jem.20072041"},{"key":"18","doi-asserted-by":"crossref","unstructured":"22.\u7ab6\u30fbambaT,McDonaldDM:Mechanisms of adverse effects of anti-VEGF therapy for cancer.Br J Cancer2007;96:1788\u7ab6\u9aad\u00801795.","DOI":"10.1038\/sj.bjc.6603813"},{"key":"19","doi-asserted-by":"crossref","unstructured":"23.\u7ab6\u30fbreminaV,SoodM,HaighJ,NagyA,LajoieG,FerraraN,GerberHP,KikkawaY,MinerJH,QuagginSE:Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.J Clin Invest2003;111:707\u7ab6\u9aad\u0080716.","DOI":"10.1172\/JCI200317423"},{"key":"20","doi-asserted-by":"crossref","unstructured":"24.\u7ab6\u30fberberHP,MalikAK,SolarGP,ShermanD,LiangXH,MengG,HongK,MarstersJC,FerraraN:VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.Nature2002;417:954\u7ab6\u9aad\u0080958.","DOI":"10.1038\/nature00821"},{"key":"21","unstructured":"25.\u7ab6\u30fbangJC,HaworthL,SherryRM,HwuP,SchwartzentruberDJ,TopalianSL,SteinbergSM,ChenHX,RosenbergSA:A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.N Engl J Med2003;349:427\u7ab6\u9aad\u0080434The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene."},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2639"},{"key":"23","doi-asserted-by":"crossref","unstructured":"28.\u7ab6\u30fbohYJ,KimHZ,HwangSI,LeeJE,OhN,JungK,KimM,KimKE,KimH,LimNK,JeonCJ,LeeGM,JeonBH,NamDH,SungHK,NagyA,YooOJ,KohGY:Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage.Cancer Cell2010;18:171\u7ab6\u9aad\u0080184.","DOI":"10.1016\/j.ccr.2010.07.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"29.\u7ab6\uff14aharinenP,EklundL,PulkkiK,BonoP,AlitaloK: VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med2011; [Epub ahead of print].","DOI":"10.1016\/j.molmed.2011.01.015"},{"key":"25","doi-asserted-by":"crossref","unstructured":"30.\u7ab6\u30fbohyeldinA,Garzon-MuvdiT,Quinones-HinojosaA:Oxygen in stem cell biology: a critical component of the stem cell niche.Cell Stem Cell2010;7:150\u7ab6\u9aad\u0080161.","DOI":"10.1016\/j.stem.2010.07.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"31.\u7ab6\u30fbbosJM,LeeCR,Cruz-MunozW,BjarnasonGA,ChristensenJG,KerbelRS:Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.Cancer Cell2009;15:232\u7ab6\u9aad\u0080239.","DOI":"10.1016\/j.ccr.2009.01.021"},{"key":"27","doi-asserted-by":"crossref","unstructured":"32.\u7ab6\uff11aez-RibesM,AllenE,HudockJ,TakedaT,OkuyamaH,VinalsF,InoueM,BergersG,HanahanD,CasanovasO:Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.Cancer Cell2009;15:220\u7ab6\u9aad\u0080231.","DOI":"10.1016\/j.ccr.2009.01.027"},{"key":"28","doi-asserted-by":"crossref","unstructured":"34.\u7ab6\uff11aderaTP,KuoAH,HoshidaT,LiaoS,LoboJ,KozakKR,FukumuraD,JainRK:Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib.Mol Cancer Ther2008;7:2272\u7ab6\u9aad\u00802279.","DOI":"10.1158\/1535-7163.MCT-08-0182"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.161521"},{"key":"30","doi-asserted-by":"crossref","unstructured":"36.\u7ab6\u30fbellbergC,OstmanA,HeldinCH:PDGF and vessel maturation.Recent Results Cancer Res2010;180:103\u7ab6\u9aad\u0080114.","DOI":"10.1007\/978-3-540-78281-0_7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"37.\u7ab6\uff18angR,ChadalavadaK,WilshireJ,KowalikU,HovingaKE,GeberA,FligelmanB,LevershaM,BrennanC,TabarV:2010 Glioblastoma stem-like cells give rise to tumour endothelium.Nature2010;468:829\u7ab6\u9aad\u0080833.","DOI":"10.1038\/nature09624"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1038\/nature09557"},{"key":"33","doi-asserted-by":"crossref","unstructured":"39.\u7ab6\u30fberraraN:Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.Curr Opin Hematol2010;17:219\u7ab6\u9aad\u0080224.","DOI":"10.1097\/MOH.0b013e3283386660"},{"key":"34","unstructured":"40.\u7ab6\u30fberbelRS,YuJ,TranJ,ManS,Viloria-PetitA,KlementG,CoomberBL,RakJ:Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.Cancer Metastasis Rev2001;20:79\u7ab6\u9aad\u008086."},{"key":"35","doi-asserted-by":"crossref","unstructured":"42.\u7ab6\u30fbuC,BonomeT,LiY,KamatAA,HanLY,SchmandtR,ColemanRL,GershensonDM,JaffeRB,BirrerMJ,SoodAK:Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.Cancer Res2007;67:1757\u7ab6\u9aad\u00801768.","DOI":"10.1158\/0008-5472.CAN-06-3700"},{"key":"36","doi-asserted-by":"crossref","unstructured":"43.\u7ab6\u30fbuC,HanHD,MangalaLS,Ali-FehmiR,NewtonCS,OzbunL,Armaiz-PenaGN,HuW,StoneRL,MunkarahA,RavooriMK,ShahzadMM,LeeJW,MoraE,LangleyRR,CarrollAR,MatsuoK,SpannuthWA,SchmandtR,JenningsNB,GoodmanBW,JaffeRB,NickAM,KimHS,GuvenEO,ChenYH,LiLY,HsuMC,ColemanRL,CalinGA,DenkbasEB,LimJY,LeeJS,KundraV,BirrerMJ,HungMC,Lopez-BeresteinG,SoodAK:Regulation of tumor angiogenesis by EZH2.Cancer Cell2010;18:185\u7ab6\u9aad\u0080197.","DOI":"10.1016\/j.ccr.2010.06.016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"44.\u7ab6\uff14atoY,SonodaH:The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.Arterioscler Thromb Vasc Biol2007;27:37\u7ab6\u9aad\u008041.","DOI":"10.1161\/01.ATV.0000252062.48280.61"},{"key":"38","unstructured":"45.\u7ab6\u30fboshidaH,HayashiS,KunisadaT,OgawaM,NishikawaS,OkamuraH,SudoT,ShultzLD,NishikawaS.Nature1990;345:442\u7ab6\u9aad\u0080444."},{"key":"39","doi-asserted-by":"crossref","unstructured":"46.\u7ab6\u30fbecchiniMG,DominguezMG,MocciS,WetterwaldA,FelixR,FleischH,ChisholmO,HofstetterW,PollardJW,StanleyER:Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.Development1994;120:1357\u7ab6\u9aad\u00801372.","DOI":"10.1242\/dev.120.6.1357"},{"key":"40","doi-asserted-by":"crossref","unstructured":"47.\u7ab6\u30fbubotaY,TakuboK,ShimizuT,OhnoH,KishiK,ShibuyaM,SayaH,SudaT:M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.J Exp Med2009;206:1089\u7ab6\u9aad\u00801102.","DOI":"10.1084\/jem.20081605"},{"key":"41","doi-asserted-by":"crossref","unstructured":"49.\u7ab6\uff13ymoSF,GerhardtH,Wolfhagen SandF,LangR,UvA,BetsholtzC:A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures.PLoS ONE2011;6:e15846.","DOI":"10.1371\/journal.pone.0015846"},{"key":"42","doi-asserted-by":"crossref","unstructured":"52.\u7ab6\uff14icaA,BronteV:Altered macrophage differentiation and immune dysfunction in tumor development.J Clin Invest2007;117:1155\u7ab6\u9aad\u00801166.","DOI":"10.1172\/JCI31422"},{"key":"43","unstructured":"53.\u7ab6\uff13olnyC,MazzoneM,TuguesS,LaouiD,JohanssonI,CoulonC,SquadritoML,SeguraI,LiX,KnevelsE,CostaS,VinckierS,DresselaerT,AkerudP,De MolM,SalomakiH,PhillipsonM,WynsS,LarssonE,BuysschaertI,BotlingJ,HimmelreichU,Van GinderachterJA,De PalmaM,DewerchinM,Claesson-WelshL,CarmelietP:HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.Cancer Cell2011;19:31\u7ab6\u9aad\u008044."},{"key":"44","doi-asserted-by":"crossref","unstructured":"54.\u7ab6\uff18ernoC,MenradH,WeigertA,DehneN,GoerdtS,SchledzewskiK,KzhyshkowskaJ,BruneB:Knockout of HIF-1\u03b1 in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses.Carcinogenesis2010;31:1863\u7ab6\u9aad\u00801872.","DOI":"10.1093\/carcin\/bgq088"},{"key":"45","doi-asserted-by":"crossref","unstructured":"55.\u7ab6\u30fbiaoX,SharmaN,KapadiaF,ZhouG,LuY,HongH,ParuchuriK,MahabeleshwarGH,DalmasE,VenteclefN,FlaskCA,KimJ,DoreianBW,LuKQ,KaestnerKH,HamikA,ClementK,JainMK:Kruppel-like factor 4 regulates macrophage polarization.J Clin Invest2011;121:2736\u7ab6\u9aad\u00802749.","DOI":"10.1172\/JCI45444"},{"key":"46","doi-asserted-by":"crossref","unstructured":"56.\u7ab6\uff18hyteCS,BishopET,RuckerlD,Gaspar-PereiraS,BarkerRN,AllenJE,ReesAJ,WilsonHM: Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol2011; [Epub ahead of print].","DOI":"10.1189\/jlb.1110644"},{"key":"47","doi-asserted-by":"crossref","unstructured":"57.\u7ab6\u30fbinEY,LiJF,GnatovskiyL,DengY,ZhuL,GrzesikDA,QianH,XueXN,PollardJW:Macrophages regulate the angiogenic switch in a mouse model of breast cancer.Cancer Res2006;66:11238\u7ab6\u9aad\u008011246.","DOI":"10.1158\/0008-5472.CAN-06-1278"},{"key":"48","doi-asserted-by":"crossref","unstructured":"60.\u7ab6\u30fbainRK:Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.Science2005;307:58\u7ab6\u9aad\u008062.","DOI":"10.1126\/science.1104819"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.020"},{"key":"50","doi-asserted-by":"crossref","unstructured":"63.\u7ab6\uff14t CroixB,RagoC,VelculescuV,TraversoG,RomansKE,MontgomeryE,LalA,RigginsGJ,LengauerC,VogelsteinB,KinzlerKW:Genes expressed in human tumor endothelium.Science2000;289:1197\u7ab6\u9aad\u00801202.","DOI":"10.1126\/science.289.5482.1197"},{"key":"51","doi-asserted-by":"crossref","unstructured":"64.\u7ab6\u30fbidaK,KlagsbrunM:A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.Cancer Res2005;65:2507\u7ab6\u9aad\u00802510.","DOI":"10.1158\/0008-5472.CAN-05-0002"},{"key":"52","doi-asserted-by":"crossref","unstructured":"67.\u7ab6\u30fbasanovasO,HicklinDJ,BergersG,HanahanD:Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.Cancer Cell2005;8:299\u7ab6\u9aad\u0080309.","DOI":"10.1016\/j.ccr.2005.09.005"},{"key":"53","doi-asserted-by":"crossref","unstructured":"69.\u7ab6\u30fbguayoA,KantarjianH,ManshouriT,GidelC,EsteyE,ThomasD,KollerC,EstrovZ,O\u2019BrienS,KeatingM,FreireichE,AlbitarM:Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.Blood2000;96:2240\u7ab6\u9aad\u00802245.","DOI":"10.1182\/blood.V96.6.2240.h8002240_2240_2245"},{"key":"54","doi-asserted-by":"crossref","unstructured":"70.\u7ab6\u30fbiWW,HutnikM,GehrG:Antiangiogenesis in haematological malignancies.Br J Haematol2008;143:622\u7ab6\u9aad\u0080631.","DOI":"10.1111\/j.1365-2141.2008.07372.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"71.\u7ab6\uff14chmidtT,Kharabi MasoulehB,LogesS,CauwenberghsS,FraislP,MaesC,JonckxB,De KeersmaeckerK,KleppeM,TjwaM,SchenkT,VinckierS,FragosoR,De MolM,BeelK,DiasS,VerfaillieC,ClarkRE,BrummendorfTH,VandenbergheP,RafiiS,HolyoakeT,HochhausA,CoolsJ,KarinM,CarmelietG,DewerchinM,CarmelietP:Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1(+).Leukemia. Cancer Cell2011;19:740\u7ab6\u9aad\u0080753.","DOI":"10.1016\/j.ccr.2011.05.007"},{"key":"56","doi-asserted-by":"crossref","unstructured":"72.\u7ab6\uff13akhraK,BachireddyP,ZabuawalaT,ZeiserR,XuL,KopelmanA,FanAC,YangQ,BraunsteinL,CrosbyE,RyeomS,FelsherDW:CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.Cancer Cell2010;18:485\u7ab6\u9aad\u0080498.","DOI":"10.1016\/j.ccr.2010.10.002"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/61\/2\/61_47\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:11:09Z","timestamp":1656555069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/61\/2\/61_47\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.61.47","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}